The new semi-quantitative VIDAS® SARS-COV-2 IgG tests supports in the assessment of Immune Status of patients (Post- Infection or Post Vaccination). It targets the RBD/S protein and has excellent correlation to the WHO international Standard in BAU/mL (Binding Antibody Units/mL). The document provides a conversion chart showing Index values and the corresponding BAU/mL values.
The new semi-quantitative VIDAS® SARS-COV-2 IgG tests supports in the assessment of Immune Status of patients (Post- Infection or Post Vaccination). It targets the RBD/S protein and has excellent correlation to the WHO international Standard in BAU/mL (Binding Antibody Units/mL). The document provides a conversion chart showing Index values and the corresponding BAU/mL values.
The new semi-quantitative VIDAS® SARS-COV-2 IgG tests supports in the assessment of Immune Status of patients (Post- Infection or Post Vaccination). It targets the RBD/S protein and has excellent correlation to the WHO international Standard in BAU/mL (Binding Antibody Units/mL). The document provides a conversion chart showing Index values and the corresponding BAU/mL values.
The new semi-quantitative VIDAS® SARS-COV-2 IgG tests supports in the assessment of Immune Status of patients (Post- Infection or Post Vaccination). It targets the RBD/S protein and has excellent correlation to the WHO international Standard in BAU/mL (Binding Antibody Units/mL). The document provides a conversion chart showing Index values and the corresponding BAU/mL values.
The new semi-quantitative VIDAS® SARS-COV-2 IgG tests supports in the assessment of Immune Status of patients (Post- Infection or Post Vaccination) SARS-COV-2 IgG test targets RBD/S protein, with excellent correlation to the WHO international Standard in BAU/mL (Binding Antibody Units/mL).